Chen, Ming <br/><br/>
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.  [electronic resource] 

 -  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics  Jan 2016 
 - 34-8 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-3479 
<br/><br/><label>Standard No.: </label>10.1016/j.ijgo.2015.06.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>China<br/>Disease-Free Survival<br/>Endometrial Hyperplasia--drug therapy<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Fertility--drug effects<br/>Fertility Preservation--methods<br/>Humans<br/>Medroxyprogesterone Acetate--administration & dosage<br/>Megestrol Acetate--administration & dosage<br/>Neoplasm Recurrence, Local<br/>Obesity--complications<br/>Pregnancy<br/>Progestins--administration & dosage<br/>Recurrence<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult